The double-edged sword of long non-coding RNA: The role of human brain-specific BC200 RNA in translational control, neurodegenerative diseases, and cancer

Mutation Research - Reviews in Mutation Research

Volumn 766, Issue , 2015, Pages 58-67

  Sosińska, Patrycja ^a   Mikuła Pietrasik, Justyna ^a   Ksiazek, Krzysztof ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

BC200 RNA; Neurodegeneration; Non coding RNA

Indexed keywords

BC200 RNA; LONG UNTRANSLATED RNA; RNA; UNCLASSIFIED DRUG; BC1 RNA; SMALL CYTOPLASMIC RNA;

DEGENERATIVE DISEASE; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; REVIEW; ANIMAL; BRAIN; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEOPLASM; PATHOLOGY; PROTEIN SYNTHESIS;

ANIMALS; BRAIN; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PROTEIN BIOSYNTHESIS; RNA, LONG NONCODING; RNA, SMALL CYTOPLASMIC;

EID: 84947613066     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2015.08.002     Document Type: Review

References (115)

1. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
2. McPherson J.D., Marra M., Hillier L., Waterston R.H., Chinwalla A., Wallis J., Sekhon M., Wylie K., Mardis E.R., Wilson R.K., Fulton R., Kucaba T.A., Wagner-McPherson C., et al. A physical map of the human genome. Nature 2001, 409:934-941.
3. Pollard K.S., Salama S.R., Lambert N., Lambot M.A., Coppens S., Pedersen J.S., Katzman S., King B., Onodera C., Siepel A., Kern A.D., Dehay C., Igel H., et al. An RNA gene expressed during cortical development evolved rapidly in humans. Nature 2006, 443:167-172.
4. Costa F.F. Non-coding RNAs new players in eukaryotic biology. Gene 2005, 357:83-94.
5. Grivna S.T., Beyret E., Wang Z., Lin H. A novel class of small RNAs in mouse spermatogenic cells. Genes Dev. 2006, 20:1709-1714.
6. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
7. Monroig P.D., Chen L., Zhang S., Calin G.A. Small molecule compounds targeting miRNAs for cancer therapy. Adv. Drug Deliv. Rev. 2014.
8. Gstir R., Schafferer S., Scheideler M., Misslinger M., Griehl M., Daschil N., Humpel C., Obermair G.J., Schmuckermair C., Striessnig J., Flucher B.E., Huttenhofer A. Generation of a neuro-specific microarray reveals novel differentially expressed noncoding RNAs in mouse models for neurodegenerative diseases. RNA 2014, 20:1929-1943.
9. Lee S.T., Chu K., Im W.S., Yoon H.J., Im J.Y., Park J.E., Park K.H., Jung K.H., Lee S.K., Kim M., Roh J.K. Altered microRNA regulation in Huntington's disease models. Exp. Neurol. 2011, 227:172-179.
10. Cheng C.J., Bahal R., Babar I.A., Pincus Z., Barrera F., Liu C., Svoronos A., Braddock D.T., Glazer P.M., Engelman D.M., Saltzman W.M., Slack F.J. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 2014.
11. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
12. ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
13. Cao J. The functional role of long non-coding RNAs and epigenetics. Biol. Proced. Online 2014, 16:11.
14. Peng W., Gao W., Feng J. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Med. Oncol. 2014, 31:346.
15. Yin D., He X., Zhang E., Kong R., De W., Zhang Z. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med. Oncol. 2014, 31:253.
16. Li L.J., Zhu J.L., Bao W.S., Chen D.K., Huang W.W., Weng Z.L. Long noncoding RNA GHET1 promotes the development of bladder cancer. Int. J. Clin. Exp. Pathol. 2014, 7:7196-7205.
17. Yang Y.R., Zang S.Z., Zhong C.L., Li Y.X., Zhao S.S., Feng X.J. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 2014, 7:6929-6935.
18. Qiu J.J., Lin Y.Y., Ye L.C., Ding J.X., Feng W.W., Jin H.Y., Zhang Y., Li Q., Hua K.Q. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol. Oncol. 2014, 134:121-128.
19. Liu X.H., Liu Z.L., Sun M., Liu J., Wang Z.X., De W. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 2013, 13:464.
20. Chen F.J., Sun M., Li S.Q., Wu Q.Q., Ji L., Liu Z.L., Zhou G.Z., Cao G., Jin L., Xie H.W., Wang C.M., Lv J., De W., et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol. Carcinog. 2013, 52:908-915.
21. Kim H.J., Lee D.W., Yim G.W., Nam E.J., Kim S., Kim S.W., Kim Y.T. Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int. J. Oncol. 2014.
22. Lin N., Chang K.Y., Li Z., Gates K., Rana Z.A., Dang J., Zhang D., Han T., Yang C.S., Cunningham T.J., Head S.R., Duester G., Dong P.D., et al. An evolutionarily conserved long noncoding RNA TUNA controls pluripotency and neural lineage commitment. Mol. Cell 2014, 53:1005-1019.
23. Akula N., Barb J., Jiang X., Wendland J.R., Choi K.H., Sen S.K., Hou L., Chen D.T., Laje G., Johnson K., Lipska B.K., Kleinman J.E., Corrada-Bravo H., et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol. Psychiatry 2014, 19:1179-1185.
24. Ziats M.N., Rennert O.M. Aberrant expression of long noncoding RNAs in autistic brain. J. Mol. Neurosci. 2013, 49:589-593.
25. Smalheiser N.R. The RNA-centred view of the synapse: non-coding RNAs and synaptic plasticity. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2014, 369.
26. Chen W., Bocker W., Brosius J., Tiedge H. Expression of neural BC200 RNA in human tumours. J. Pathol. 1997, 183:345-351.
27. Iacoangeli A., Lin Y., Morley E.J., Muslimov I.A., Bianchi R., Reilly J., Weedon J., Diallo R., Bocker W., Tiedge H. BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis 2004, 25:2125-2133.
28. Mus E., Hof P.R., Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10679-10684.
29. Kung J.T., Colognori D., Lee J.T. Long noncoding RNAs: past, present, and future. Genetics 2013, 193:651-669.
30. Wright M.W. A short guide to long non-coding RNA gene nomenclature. Hum. Genomics 2014, 8:7.
31. Guttman M., Amit I., Garber M., French C., Lin M.F., Feldser D., Huarte M., Zuk O., Carey B.W., Cassady J.P., Cabili M.N., Jaenisch R., Mikkelsen T.S., et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458:223-227.
32. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec G., Martin D., Merkel A., Knowles D.G., Lagarde J., Veeravalli L., Ruan X., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
33. Cabili M.N., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011, 25:1915-1927.
34. Kiyosawa H., Mise N., Iwase S., Hayashizaki Y., Abe K. Disclosing hidden transcripts: mouse natural sense-antisense transcripts tend to be poly(A) negative and nuclear localized. Genome Res. 2005, 15:463-474.
35. Werner A. Biological functions of natural antisense transcripts. BMC Biol. 2013, 11:31.
36. Siegel T.N., Hon C.C., Zhang Q., Lopez-Rubio J.J., Scheidig-Benatar C., Martins R.M., Sismeiro O., Coppee J.Y., Scherf A. Strand-specific RNA-Seq reveals widespread and developmentally regulated transcription of natural antisense transcripts in Plasmodium falciparum. BMC Genomics 2014, 15:150.
37. Pink R.C., Wicks K., Caley D.P., Punch E.K., Jacobs L., Carter D.R. Pseudogenes pseudo-functional or key regulators in health and disease?. RNA 2011, 17:792-798.
38. Li W., Yang W., Wang X.J. Pseudogenes pseudo or real functional elements?. J. Genet. Genomics 2013, 40:171-177.
39. Harrison P.M., Zheng D., Zhang Z., Carriero N., Gerstein M. Transcribed processed pseudogenes in the human genome: an intermediate form of expressed retrosequence lacking protein-coding ability. Nucleic Acids Res. 2005, 33:2374-2383.
40. Bekpen C., Marques-Bonet T., Alkan C., Antonacci F., Leogrande M.B., Ventura M., Kidd J.M., Siswara P., Howard J.C., Eichler E.E. Death and resurrection of the human IRGM gene. PLoS Genet. 2009, 5:e1000403.
41. Elisaphenko E.A., Kolesnikov N.N., Shevchenko A.I., Rogozin I.B., Nesterova T.B., Brockdorff N., Zakian S.M. A dual origin of the Xist gene from a protein-coding gene and a set of transposable elements. PLoS One 2008, 3:e2521.
42. Rearick D., Prakash A., McSweeny A., Shepard S.S., Fedorova L., Fedorov A. Critical association of ncRNA with introns. Nucleic Acids Res. 2011, 39:2357-2366.
43. Guil S., Soler M., Portela A., Carrere J., Fonalleras E., Gomez A., Villanueva A., Esteller M. Intronic RNAs mediate EZH2 regulation of epigenetic targets. Nat. Struct. Mol. Biol. 2012, 19:664-670.
44. Core L.J., Lis J.T. Transcription regulation through promoter-proximal pausing of RNA polymerase II. Science 2008, 319:1791-1792.
45. Seila A.C., Calabrese J.M., Levine S.S., Yeo G.W., Rahl P.B., Flynn R.A., Young R.A., Sharp P.A. Divergent transcription from active promoters. Science 2008, 322:1849-1851.
46. Flynn R.A., Almada A.E., Zamudio J.R., Sharp P.A. Antisense RNA polymerase II divergent transcripts are P-TEFb dependent and substrates for the RNA exosome. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:10460-10465.
47. Kanhere A., Viiri K., Araujo C.C., Rasaiyaah J., Bouwman R.D., Whyte W.A., Pereira C.F., Brookes E., Walker K., Bell G.W., Pombo A., Fisher A.G., Young R.A., et al. Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol. Cell 2010, 38:675-688.
48. Cech T.R., Steitz J.A. The noncoding RNA revolution-trashing old rules to forge new ones. Cell 2014, 157:77-94.
49. Chalei V., Sansom S.N., Kong L., Lee S., Montiel J., Vance K.W., Ponting C.P. The long non-coding RNA is an epigenetic regulator of neural differentiation. eLife 2014, 3.
50. Mueller A.C., Cichewicz M.A., Dey B.K., Layer R., Reon B.J., Gagan J.R., Dutta A. MUNC: a lncRNA that induces the expression of pro-myogenic genes in skeletal myogenesis. Mol. Cell. Biol. 2014.
51. Hung T., Chang H.Y. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010, 7:582-585.
52. Autuoro J.M., Pirnie S.P., Carmichael G.G. Long noncoding RNAs in imprinting and X chromosome inactivation. Biomolecules 2014, 4:76-100.
53. Weinberg M.S., Morris K.V. Long non-coding RNA targeting and transcriptional de-repression. Nucleic Acid Ther. 2013, 23:9-14.
54. Hu G., Lou Z., Gupta M. The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation. PLoS One 2014, 9:e107016.
55. Yoon J.H., Abdelmohsen K., Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J. Mol. Biol. 2013, 425:3723-3730.
56. Paci P., Colombo T., Farina L. Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. BMC Syst. Biol. 2014, 8:83.
57. Pilyugin M., Irminger-Finger I. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs. Int. J. Biochem. Cell Biol. 2014, 54:356-367.
58. Yoon J.H., Abdelmohsen K., Gorospe M. Functional interactions among microRNAs and long noncoding RNAs. Semin. Cell Dev. Biol. 2014, 34:9-14.
59. Lv J., Ma L., Chen X.L., Huang X.H., Wang Q. Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3beta/Cdc25A signaling pathway. J. Huazhong Univ. Sci. Technol. Med. Sci. 2014, 34:363-369.
60. Zhu M., Chen Q., Liu X., Sun Q., Zhao X., Deng R., Wang Y., Huang J., Xu M., Yan J., Yu J. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J. 2014, 281:3766-3775.
61. Bergmann J.H., Spector D.L. Long non-coding RNAs: modulators of nuclear structure and function. Curr. Opin. Cell Biol. 2014, 26:10-18.
62. Rinn J., Guttman M. RNA Function. RNA and dynamic nuclear organization. Science 2014, 345:1240-1241.
63. Goldie B.J., Cairns M.J. Post-transcriptional trafficking and regulation of neuronal gene expression. Mol. Neurobiol. 2012, 45:99-108.
64. Martin K.C., Zukin R.S. RNA trafficking and local protein synthesis in dendrites: an overview. J. Neurosci. 2006, 26:7131-7134.
65. Bramham C.R., Wells D.G. Dendritic mRNA: transport, translation and function. Nat. Rev. Neurosci. 2007, 8:776-789.
66. Wang H., Iacoangeli A., Popp S., Muslimov I.A., Imataka H., Sonenberg N., Lomakin I.B., Tiedge H. Dendritic BC1 RNA: functional role in regulation of translation initiation. J. Neurosci. 2002, 22:10232-10241.
67. Martignetti J.A., Brosius J. BC200 RNA: a neural RNA polymerase III product encoded by a monomeric Alu element. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:11563-11567.
68. Tiedge H., Chen W., Brosius J. Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. J. Neurosci. 1993, 13:2382-2390.
69. Cheng J.G., Tiedge H., Brosius J. Expression of dendritic BC200 RNA, component of a 11.4S ribonucleoprotein particle, is conserved in humans and simians. Neurosci. Lett. 1997, 224:206-210.
70. Skryabin B.V., Kremerskothen J., Vassilacopoulou D., Disotell T.R., Kapitonov V.V., Jurka J., Brosius J. The BC200 RNA gene and its neural expression are conserved in Anthropoidea (Primates). J. Mol. Evol. 1998, 47:677-685.
71. Tiedge H., Fremeau R.T., Weinstock P.H., Arancio O., Brosius J. Dendritic location of neural BC1 RNA. Proc. Natl. Acad. Sci. U. S. A 1991, 88:2093-2097.
72. Kremerskothen J., Zopf D., Walter P., Cheng J.G., Nettermann M., Niewerth U., Maraia R.J., Brosius J. Heterodimer SRP9/14 is an integral part of the neural BC200 RNP in primate brain. Neurosci. Lett. 1998, 245:123-126.
73. Rozhdestvensky T.S., Kopylov A.M., Brosius J., Huttenhofer A. Neuronal BC1 RNA structure: evolutionary conversion of a tRNA(Ala) domain into an extended stem-loop structure. RNA 2001, 7:722-730.
74. Washietl S. Sequence and structure analysis of noncoding RNAs. Methods Mol. Biol. 2010, 609:285-306.
75. Kondrashov A.V., Kiefmann M., Ebnet K., Khanam T., Muddashetty R.S., Brosius J. Inhibitory effect of naked neural BC1 RNA or BC200 RNA on eukaryotic in vitro translation systems is reversed by poly(A)-binding protein (PABP). J. Mol. Biol. 2005, 353:88-103.
76. Cheng J.G., Tiedge H., Brosius J. Identification and characterization of BC1 RNP particles. DNA Cell Biol. 1996, 15:549-559.
77. Schuman E.M., Dynes J.L., Steward O. Synaptic regulation of translation of dendritic mRNAs. J. Neurosci. 2006, 26:7143-7146.
78. Muddashetty R., Khanam T., Kondrashov A., Bundman M., Iacoangeli A., Kremerskothen J., Duning K., Barnekow A., Huttenhofer A., Tiedge H., Brosius J. Poly(A)-binding protein is associated with neuronal BC1 and BC200 ribonucleoprotein particles. J. Mol. Biol. 2002, 321:433-445.
79. Zalfa F., Giorgi M., Primerano B., Moro A., Di P.A., Reis S., Oostra B., Bagni C. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 2003, 112:317-327.
80. Zalfa F., Adinolfi S., Napoli I., Kuhn-Holsken E., Urlaub H., Achsel T., Pastore A., Bagni C., Fragile X. mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J. Biol. Chem. 2005, 280:33403-33410.
81. Duning K., Buck F., Barnekow A., Kremerskothen J. SYNCRIP, a component of dendritically localized mRNPs, binds to the translation regulator BC200 RNA. J. Neurochem. 2008, 105:351-359.
82. Zhang X., Shan S.O. Fidelity of cotranslational protein targeting by the signal recognition particle. Annu. Rev. Biophys. 2014, 43:381-408.
83. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., Darnell R.B., Warren S.T. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 2001, 107:477-487.
84. Chen L., Yun S.W., Seto J., Liu W., Toth M. The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences. Neuroscience 2003, 120:1005-1017.
85. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., Darnell R.B., Fragile X. mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001, 107:489-499.
86. Miyashiro K.Y., Beckel-Mitchener A., Purk T.P., Becker K.G., Barret T., Liu L., Carbonetto S., Weiler I.J., Greenough W.T., Eberwine J. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 2003, 37:417-431.
87. Ramos A., Hollingworth D., Pastore A. G-quartet-dependent recognition between the FMRP RGG box and RNA. RNA 2003, 9:1198-1207.
88. Garcia M.L., Cleveland D.W. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. Curr. Opin. Cell Biol. 2001, 13:41-48.
89. Kerrigan T.L., Randall A.D. A new player in the "synaptopathy" of Alzheimer's disease - arc/arg 3.1. Front Neurol. 2013, 4:9.
90. Ly P.T., Song W. Loss of activated CaMKII at the synapse underlies Alzheimer's disease memory loss. J. Neurochem. 2011, 4:673-675.
91. Wang H., Iacoangeli A., Lin D., Williams K., Denman R.B., Hellen C.U., Tiedge H. Dendritic BC1 RNA in translational control mechanisms. J. Cell Biol. 2005, 171:811-821.
92. Iacoangeli A., Rozhdestvensky T.S., Dolzhanskaya N., Tournier B., Schutt J., Brosius J., Denman R.B., Khandjian E.W., Kindler S., Tiedge H. On BC1 RNA and the fragile X mental retardation protein. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:734-739.
93. Darnell J.C., Fraser C.E., Mostovetsky O., Stefani G., Jones T.A., Eddy S.R., Darnell R.B. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev. 2005, 19:903-918.
94. Zhong J., Chuang S.C., Bianchi R., Zhao W., Paul G., Thakkar P., Liu D., Fenton A.A., Wong R.K., Tiedge H. Regulatory BC1 RNA and the fragile X mental retardation protein: convergent functionality in brain. PLoS One 2010, 5:e15509.
95. Bannai H., Fukatsu K., Mizutani A., Natsume T., Iemura S., Ikegami T., Inoue T., Mikoshiba K. An RNA-interacting protein, SYNCRIP (heterogeneous nuclear ribonuclear protein Q1/NSAP1) is a component of mRNA granule transported with inositol 1,4,5-trisphosphate receptor type 1 mRNA in neuronal dendrites. J. Biol. Chem. 2004, 279:53427-53434.
96. Elvira G., Wasiak S., Blandford V., Tong X.K., Serrano A., Fan X., del R.S.-C., Servant F., Bell A.W., Boismenu D., Lacaille J.C., McPherson P.S., DesGroseillers L., et al. Characterization of an RNA granule from developing brain. Mol. Cell. Proteomics 2006, 5:635-651.
97. Grosset C., Chen C.Y., Xu N., Sonenberg N., Jacquemin-Sablon H., Shyu A.B. A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex. Cell 2000, 103:29-40.
98. Mizutani A., Fukuda M., Ibata K., Shiraishi Y., Mikoshiba K. SYNCRIP, a cytoplasmic counterpart of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin isoforms. J. Biol. Chem. 2000, 275:9823-9831.
99. Kremerskothen J., Nettermann M., op de B.A., Bachmann M., Brosius J. Identification of human autoantigen La/SS-B as BC1/BC200 RNA-binding protein. DNA Cell Biol. 1998, 17:751-759.
100. Johnson E.M., Kinoshita Y., Weinreb D.B., Wortman M.J., Simon R., Khalili K., Winckler B., Gordon J. Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J. Neurosci. Res. 2006, 83:929-943.
101. Ohashi S., Kobayashi S., Omori A., Ohara S., Omae A., Muramatsu T., Li Y., Anzai K. The single-stranded DNA- and RNA-binding proteins pur alpha and pur beta link BC1 RNA to microtubules through binding to the dendrite-targeting RNA motifs. J. Neurochem. 2000, 75:1781-1790.
102. Eom T., Berardi V., Zhong J., Risuleo G., Tiedge H. Dual nature of translational control by regulatory BC RNAs. Mol. Cell. Biol. 2011, 31:4538-4549.
103. Lin D., Pestova T.V., Hellen C.U., Tiedge H. Translational control by a small RNA: dendritic BC1 RNA targets the eukaryotic initiation factor 4A helicase mechanism. Mol. Cell. Biol. 2008, 28:3008-3019.
104. Eom T., Muslimov I.A., Tsokas P., Berardi V., Zhong J., Sacktor T.C., Tiedge H., Neuronal B.C. RNAs cooperate with eIF4B to mediate activity-dependent translational control. J. Cell Biol. 2014, 207:237-252.
105. Arendt T., Bruckner M.K. Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity. Biochim. Biophys. Acta 2007, 1772:413-421.
106. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., Finch C.E., St L.G., Kenny P.J., Wahlestedt C. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 2008, 14:723-730.
107. Nelson P.T., Wang W.X., Rajeev B.W. MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol. 2008, 18:130-138.
108. Heggland I., Storkaas I.S., Soligard H.T., Kobro-Flatmoen A., Witter M.P. Stereological estimation of neuron number and plaque load in the hippocampal region of a transgenic rat model of Alzheimer's disease. Eur. J. Neurosci. 2015.
109. Mandelkow E., Mandelkow E.M. Kinesin motors and disease. Trends Cell Biol. 2002, 12:585-591.
110. Zhong J., Chuang S.C., Bianchi R., Zhao W., Lee H., Fenton A.A., Wong R.K., Tiedge H. BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J. Neurosci. 2009, 29:9977-9986.
111. Leuba G., Walzer C., Vernay A., Carnal B., Kraftsik R., Piotton F., Marin P., Bouras C., Savioz A. Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction. Neurobiol. Dis. 2008, 30:408-419.
112. Wang H. Fragile X mental retardation protein: from autism to neurodegenerative disease. Front. Cell. Neurosci. 2015, 9:43.
113. Centonze D., Rossi S., Napoli I., Mercaldo V., Lacoux C., Ferrari F., Ciotti M.T., De C., VP, rosperetti C., Maccarrone M., Fezza F., Calabresi P., Bernardi G., et al. The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum. J. Neurosci. 2007, 27:8885-8892.
114. Muslimov I.A., Lin Y., Heller M., Brosius J., Zakeri Z., Tiedge H. A small RNA in testis and brain: implications for male germ cell development. J. Cell Sci. 2002, 115:1243-1250.
115. Shi X., Sun M., Liu H., Yao Y., Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013, 339:159-166.